Surgical results for small cell lung cancer based on the new TNM staging system

Masayoshi Inoue, Shinichiro Miyoshi, Tsutomu Yasumitsu, Takashi Mori, Keiji Iuchi, Hajime Maeda, Hikaru Matsuda

Research output: Contribution to journalArticlepeer-review

99 Citations (Scopus)


Background. Operation with combined chemotherapy has been recently recommended for very early stage of small cell lung cancer without lymph node metastasis. Methods. A retrospective study was undertaken in 91 patients who had undergone pulmonary resection for small cell lung cancer according to the new international staging system. Results. The 5-year overall probability of survival was 37.1%. The 5-year survival rate was 100% for p-stage 0, 56.1% for p-stage IA, 30.0% for p-stage IB, 57.1% for p-stage IIA, and 42.9% for p-stage IIB. In the p-stage IA-IIB patients who underwent a complete resection, the 5-year survival rate of the patients treated by operation with chemotherapy was better than that of patients treated by operation alone. In addition, the 5-year survival rate of the patients who had four or more courses of chemotherapy was 80.0%. Conclusions. These results suggest that operation should be considered for p-stage IA-IIB patients and more than four courses of combined chemotherapy might be desirable in these resectable cases. (C) 2000 by The Society of Thoracic Surgeons.

Original languageEnglish
Pages (from-to)1615-1619
Number of pages5
JournalAnnals of Thoracic Surgery
Issue number5
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Surgical results for small cell lung cancer based on the new TNM staging system'. Together they form a unique fingerprint.

Cite this